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Background and Scope of This  
Guidance Document
This supplement to The Hastings Center’s “Ethical 
Framework” aims to help structure time-sensitive dis-
cussion of significant, foreseeable ethical concerns in 
responding to Covid-19 and to support collaboration 
across institutions throughout pandemic response and 
recovery. It is designed for use by county health sys-
tems and by hospitals, community health centers, and 
other health care organizations responsible for patient 
care or preventive health, including vaccine education, 
vaccine distribution, and vaccination. This document 
aims to support formal and informal convening and 
policy work within the same geographic region, such 
as a municipality, county, metropolitan area, state, or 
multistate area, led by public health authorities, health 
care institutions, or other groups involved in vaccine 
allocation. The document’s scope is limited to the ethics 
of vaccine distribution within the United States; it does 
not address the ethics of international cooperation and 
sharing vaccines versus focusing solely on ensuring 
vaccine access in one’s own nation (“vaccine national-
ism”). 
The focus of this document is the middle tier of 
vaccine allocation and the ethical challenges arising in 
the U.S. in the first half of 2021. This focus reflects gen-
eral consensus and ongoing implementation concern-
ing highest-priority vaccination of two populations: 
frontline health care workers and residents of long-
term care facilities (the groups constituting “Phase 1a” 
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in recommendations from the Advisory Committee on 
Immunization Practices [ACIP]).1 The ethical justifica-
tion for prioritizing these populations was their high 
risk of contracting the virus, of passing it to others at 
high risk of severe disease, and, in the case of long-term 
care residents, of dying of severe Covid-19. Additional 
justifications include the relatively small size of these 
initial cohorts, the relative ease of locating them and 
providing the vaccine, and the value of public trust cre-
ated by witnessing health professionals receiving the 
vaccine. There is also broad consensus that vaccine al-
location to the general public—people without major 
risk factors and who can reasonably protect themselves 
through masking and physical distancing—should oc-
cur only after the vaccination of groups at high risk of 
infection or at high risk of severe illness or death if in-
fected. This document therefore does not address the 
final stages of vaccine distribution to lower-risk mem-
bers of the public. 
This document assumes that states, organizations, 
and other localities will aim to follow the general guid-
ance provided by the ACIP. The purpose of this docu-
ment is to provide more detailed ethical guidance sup-
porting allocation after phase 1a of the ACIP guidance 
and before widespread availability of the vaccine to the 
general public. This document positions equity—fair-
ness in how benefits and burdens are distributed across 
a society—as a cross-cutting consideration at all phases 
of allocation. Equity in vaccine allocation helps to mit-
igate the consequences of underlying socioeconomic 
and racial inequalities that create higher risk. 
For example, we have offered an alternative ap-
proach to the ACIP’s use of blunt age cutoffs as a sole 
criterion for vaccine allocation. Our alternative ap-
proach is grounded in data, aims at greater effective-
ness, and supports equitable allocation to minority 
populations who experience Covid-19 mortality and 
morbidity at earlier ages than the majority population. 
We have also extended the ACIP’s attention to 
“high-risk settings” to include neighborhoods with high 
infection rates. We suggest evidence-based tools for use 
in prioritizing vaccine allocation by neighborhood us-
ing local public health data. This population-health ap-
proach supports equitable and efficient use of a limited 
vaccine supply by targeting areas where many residents 
live in overcrowded housing or face other risk factors 
associated with socioeconomic inequalities.
Vaccine hesitancy—avoidance or refusal of a vac-
cine when it is offered—is more prevalent in historically 
marginalized populations. These populations are often 
at greater risk of contracting or transmitting the virus 
due to environmental working or living conditions and 
may be at greater risk of severe Covid-19 illness. In-
equity results if lower-risk populations are vaccinated 
ahead of higher-risk populations due to vaccine hesi-
tancy. This document therefore recommends proactive 
response to vaccine skepticism and hesitancy as part of 
ethical and effective vaccine allocation. Ongoing out-
reach to and engagement of higher-risk populations, 
within prioritized groups and subsequently among the 
general public, is crucial to preventing inequities in up-
take of the vaccine and in protection from Covid-19.
The middle tier of vaccine allocation (designated 
“Phase 1b” and “Phase 1c” in ACIP recommendations 
and referred to in various ways by states, organizations, 
and other localities) comprises people with a high 
risk of severe disease or death if they become infect-
ed, based on their personal medical and social factors; 
people who live or work in high-risk settings outside 
of health care facilities, and certain “essential” workers 
beyond frontline health care workers. The ethics of al-
locating and distributing vaccines within and between 
these groups will be a major challenge in months ahead, 
when vaccine supplies will continue to fall short of de-
mand and as the logistics of vaccinating groups outside 
of health care or long-term care settings becomes more 
complex.
This document also briefly considers the role of 
vaccination in health justice. Ethical deliberation in-
cludes the extent to which vaccine prioritization, vac-
cine education, and vaccination can help to mitigate 
the consequences of historical and continuing socio-
1 In October 2020, the National Academy of Medicine (NASEM) released a framework for equitable coronavirus vaccine alloca-
tion that aims to mitigate health inequities evident in Covid-19 epidemiological data by giving higher priority to communities 
with more medical and social vulnerabilities associated with greater risk of severe Covid-19 (NASEM, 2020; Kolata, 2020).
Interim recommendations from CDC’s Advisory Committee on Immunization Practices (ACIP) released in early December to 
guide initial vaccine allocation placed health care workers and residents of long-term care facilities in the first tier (Dooling et 
al., 2020a). Further ACIP recommendations were released on December 20, covering the middle tiers of prioritization— after 
phase 1a and before the general public (Dooling et al., 2020b). Vaccination of health care workers in the U.S. began on Decem-
ber 14, 2020.
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economic and racial inequalities that produce health 
disparities.
This document is not intended to be, and should 
not be considered, a substitute for clinical ethics con-
sultation or other medical, legal, or other professional 
advice on individual cases or for particular institutions. 
It reflects an evolving public health emergency and 
the rapid development and updating of public health 
and clinical practice guidance and institutional proto-
cols; references are current as of January 15, 2021. This 
rapid-response work is made possible by The Hastings 
Center Impact Fund.
Summary of Ethical Framework 
(updated January 2021, based on March 2020 Ethical 
Framework and April 2020 and July 2020 Supplements; 
see end of document for citations)
Public health and health care leaders have a duty to 
plan for the management of foreseeable ethical chal-
lenges during a public health emergency.
l Ethical challenges arise when there is uncer-
tainty about how to “do the right thing” when duties 
or values conflict. These challenges affect current and 
prospective patients, the health care workforce, health 
care operations, and a health care institution’s com-
munication with the public.
l The duty to plan for the management of foresee-
able ethical challenges arising in middle-tier Covid-19 
vaccine allocation encompasses how health care in-
stitutions and larger organizations should distribute 
periodic shipments of vaccines that will be in short 
supply relative to demand among prioritized popula-
tions. The duty to plan also encompasses the logistics 
of vaccine allocation, vaccine education, and vaccina-
tion to groups and sites beyond health care personnel 
and long-term care facility residents.
l The duty to plan entails developing contingency 
plans for foreseeable challenges during the allocation 
process. Contingency plans should cover these alloca-
tion challenges: 
	 n People in a prioritized group initially decline 
 the vaccine.
• Contingency plans should describe how 
communication should be targeted to achieve 
greater uptake among people who are initially 
hesitant to be vaccinated, including ensuring 
that these individuals have opportunities to 
discuss their concerns and have further op-
portunities to be vaccinated.
• The plans should also indicate at what 
point vaccine allocation should move or ex-
tend to the next prioritized group.
	 n There are not enough vaccine doses to 
 complete vaccination of a prioritized group.
• When feasible, the group should be pri-
oritized by subgroups, determined based on 
factors such as risk of severe Covid 19, risk of 
infection and transmission, and efficacy.
• If subgroups are essentially tied in terms 
of their potential for benefit, a random alloca-
tion protocol (lottery) should be used.
• First come, first served is not usually 
an ethically defensible allocation approach 
because it tends to work to the advantage of 
people with greater health and resources. This 
approach could be used within a subgroup if 
it is the only feasible strategy after steps have 
been taken to mitigate disparities in access. 
For example, a mobile vaccination clinic that 
provides on-site access to vaccination for res-
idents of a homeless shelter—a congregate 
setting where all residents face high risk of 
infection and transmission—might use a first-
come, first-served approach if vaccine supplies 
are insufficient to vaccinate all residents and 
devising a lottery in the time available is not 
feasible.
Public health and health care leaders have a duty to 
safeguard the health care workforce and vulnerable 
populations in the community. 
l The health care workforce includes clinicians 
caring for Covid-19 patients, such as physicians, 
nurses, and respiratory technicians, and other essen-
tial frontline workers, including janitors and house-
keeping staff, who have face-to-face patient contact 
or work within six feet of patients. These groups, and 
long-term care facility staff, were prioritized in phase 
1a of vaccination. Limited vaccine supplies mean that 
not all frontline health care workers have had early ac-
cess to vaccination.
l A community’s frontline health care workforce is 
not limited to the employees of a single institution or 
system nor to those working in hospitals, clinics, or 
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long-term care facilities. Home health aides, for ex-
ample, are members of the frontline health care work-
force who may be employed by health systems, home 
health agencies, or directly by clients.
l Vulnerable populations include people at risk 
for severe Covid-19 illness due to factors such as age 
or underlying health conditions, people facing barri-
ers to health care access, and people at increased risk 
of infection or illness due to environmental risks, 
such as occupational hazards, risks posed by congre-
gate housing or carceral or detention settings, or the 
inability to practice social distancing or use personal 
protective equipment. Persons who live in the same 
household as a member of the health care workforce 
or another person at risk of workplace infection may 
also make up a vulnerable population. 
l Public health duties to vulnerable populations 
extend to noncitizens and do not depend on immigra-
tion status. These duties derive from the core ethical 
principle that all humans have equal intrinsic moral 
worth, and they are reflected in health-related rights 
such as the right to emergency medical treatment. 
Effective distribution of vaccines to neighborhoods 
with high infection rates should reach all individuals, 
including undocumented immigrants, who work or 
live in high-risk environments associated with viral 
transmission.
l Social inequality creates vulnerable popula-
tions. Examples of health vulnerabilities derived from 
racism and prevalent among racialized minority pop-
ulations include experiences of bias in health care, 
disproportionately high rates of comorbid conditions, 
elevated rates of incarceration, hazardous work con-
ditions, and overcrowded housing, among others. 
Clinical and epidemiological data indicate that these 
vulnerabilities are associated with higher risk of se-
vere Covid-19 illness and mortality among racialized 
minority populations (Kolata, 2020b). Data also show 
that racialized minority populations are vulnerable to 
Covid-19 illness and mortality earlier in life compared 
to white populations (Bassett et al., 2020).
l Research suggests that vaccination is highly ef-
fective in protecting most vaccinated individuals from 
Covid-19. Prioritizing populations at highest risk of 
developing severe Covid-19 illness or populations at 
high risk of infection who are unable to protect them-
selves through physical distancing and other measures 
is consistent with the duty to safeguard vulnerable 
populations. Preventing viral spread, including among 
vaccinated persons, will continue to rely on preventive 
measures such as masks and physical distancing until 
it is clear whether and to what extent vaccination pre-
vents viral spread through preventing infection or un-
til a sufficient percent of the population is vaccinated 
to achieve the goal of community (“herd”) immunity.
Public health and health care leaders have a duty to 
guide health care workers, administrators, and oth-
ers experiencing demanding work conditions, ethi-
cal uncertainty, and moral distress during a public 
health emergency.
l States, organizations, and other localities are 
charged with carrying out federal vaccine allocation 
guidance that is not as detailed or operationally com-
plete as is needed for real-world implementation, 
especially for the middle tier of allocation, which 
involves multiple populations and settings. This sit-
uation places ethical, logistical, and communication 
stresses on public health leaders and administrators 
in states, organizations, or other localities that will be 
allocated vaccines to distribute in the coming weeks 
and months. 
l State health departments have a responsibility 
to provide clear, actionable guidance to county health 
systems and to health care organizations responsible 
for vaccine education, vaccine distribution, and vac-
cination. Guidance provided by ACIP and NASEM, 
while useful and important, leaves much to the discre-
tion of policy makers and organizational leadership, 
with the potential for wide variation in how vaccines 
are distributed in different states and organizations. 
For example, the power of interest groups represent-
ing workers at relatively low risk of infection could 
potentially direct vaccine allocation away from more 
vulnerable populations. Health care workers respon-
sible for Covid-19 patient care and for supporting the 
rollout of vaccine campaigns should feel confident 
that limited vaccine supplies are reaching the most 
vulnerable populations, rather than those with the 
greatest political power.
l Stigma associated with incarceration could de-
lay vaccination of people in jails and prisons despite 
their vulnerability in these environments. As yet, it 
is unclear who will have authority to make decisions 
about who gets vaccinated in immigration detention 
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facilities, where delayed or denied medical care has 
long been a major problem. 
l Anti-immigrant policies and rhetoric at the federal 
and state levels that have blocked or had chilling ef-
fects on health care access for immigrant populations 
could delay vaccination of immigrants who work or 
live in high-risk environments associated with viral 
transmission (Page and Flores-Miller, 2020). 
These duties apply across public health and 
health care institutions as well as within insti-
tutions. 
(See: Responding to Covid-19 as a Regional Public 
Health Challenge: Preliminary Guidelines for Regional 
Collaboration Involving Hospitals, https://www.thehast-
ingscenter.org/covid19-regional-ethics-guidelines/.)
l Regional collaboration can support the duty 
to plan by clarifying regional challenges, sharing re-
sources, identifying consensus, and reducing duplica-
tion and unilateral approaches in the development of 
policies and processes. 
l Regional collaboration can support the duty 
to safeguard workers and vulnerable populations by 
identifying trustworthy ways to communicate with 
vulnerable populations within a region. Communi-
cation about vaccine availability and safety and in re-
sponse to skepticism and hesitancy concerning vacci-
nation will be a key regional challenge.
l Regional collaboration can support the duty 
to guide through joint workforce training reflecting 
regional public health priorities, processes for consul-
tation and referrals across institutions, and focused 
work on mitigating social inequalities reflected in re-
gional data on health vulnerabilities. 
Emerging Ethical Challenges in  
Middle-Tier Covid-19 Vaccine Allocation 
The U.S. and global effort to develop and deliver 
safe and effective vaccines against the novel coronavi-
rus SARS-CoV-2 is occurring at unprecedented speed 
in a highly charged political context. Health care lead-
ers, such as senior administrators of hospital systems, 
long-term care facilities, county public health sys-
tems, and community health centers such as Federal-
ly Qualified Health Centers (FQHCs), are responsi-
ble for allocating shipments of vaccine in accordance 
with state-level allocation plans. These state plans are 
not uniform, and many leave considerable discretion 
to local organizations and health systems about how 
to allocate vaccines within and between prioritized 
groups. As vaccine allocation moves from hospitals and 
long-term care facilities into communities, health care 
leaders should participate in regional collaboration to 
facilitate the vaccination of at-risk populations in the 
communities they serve, using prioritization criteria 
that reflect shared values and goals. 
The following sections build on The Hastings Cen-
ter’s “Ethical Framework” (Berlinger et al., March 2020) 
to suggest how health care leaders can develop ethical-
ly sound vaccine allocation plans, respond to vaccine 
skepticism and hesitancy, and integrate health justice 
considerations into vaccine allocation. These sections 
broadly reflect the NASEM’s vaccine allocation frame-
work, which is grounded in principles of “maximum 
benefit,” “equal concern,” and “mitigation of health in-
equities” and prioritizes four groups: those at high risk 
of viral infection, those at high risk of transmitting the 
virus to others, those at high risk of severe illness, and 
those whose loss to illness would immediately harm 
others. People who fall into multiple categories get 
higher priority.
Responding to Vaccine Skepticism and  
Hesitancy 
Vaccine skepticism and hesitancy, including be-
haviors such as avoiding or refusing vaccination, are 
signal challenges to the public health goal of ending the 
pandemic by attaining community immunity through 
vaccination. The NASEM framework notes that vaccine 
hesitancy is common and increasing in the U.S. and 
that, “[p]articularly for minority communities, histo-
ries of medical research exploitation fuel understand-
able skepticism of vaccination” (NASEM, 2020).
Fulfilling the duties outlined in this document 
requires health care leaders to understand why some 
members of groups prioritized for vaccination may be 
hesitant to be vaccinated, to learn how to respond to 
vaccine hesitancy, and to draw on emerging knowledge 
concerning effective communication about Covid-19 
vaccines, including public education campaigns now 
being developed. 
Research from medical anthropology and sociol-
ogy suggests that vaccine skepticism and hesitancy 
are best understood as part of a community’s attempt 
to solve problems of risk, trustworthiness, and doubt 
and to elicit guidance and attention in a context of un-
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certainty (Larson, 2020). From this perspective, skep-
ticism and hesitancy are, in effect, efforts to “talk back 
to science” about unaddressed concerns, rather than 
a hard “antiscience” stance or evidence of scientific 
ignorance (Benjamin, 2016; Goldenberg, 2016). Ru-
mors about risks associated with vaccines, which may 
spread through communities (including via social me-
dia) whose members share ideas and values concerning 
health, should be interpreted as a form of communica-
tion about risk and harm in a context of distrust (often 
well justified) of authorities (Larson, 2020). 
One strategy for addressing distrust is to demon-
strate the value of vaccination among traditionally 
highly valued groups and individuals, such as health 
care professionals. Vaccination is underway for front-
line health care workers, many of whom are sharing 
their experiences on social media and in other ways. 
In months ahead, the growing likelihood that Amer-
icans will know someone who has been vaccinated is 
expected to contribute to public understanding and 
acceptance of the new vaccines. Many frontline health 
care workers have been eager to receive the vaccine; 
some have hesitated (Kaiser Family Foundation, 2020; 
Forbes, 2021). Vaccine hesitancy may be most common 
among minority health care workers, reflecting direct 
experience and observation of racial bias in health 
care, as well as well-documented historical examples of 
abuse (Watkins, 2020).
The task of responding effectively to vaccine skep-
ticism and hesitancy should be recognized as part of 
the duty to plan and should be embedded in every 
phase of vaccine distribution, including vaccine allo-
cation to prioritized groups. Listening to and engaging 
with individuals who may hesitate to be vaccinated; 
clarifying misinformation that contributes to vaccine 
hesitancy; maintaining a pathway to vaccination for 
people who may need more information, discussion, 
or time; and investigating gaps in uptake by prioritized 
groups are crucial activities to ensure that vaccine dis-
tribution fairly protects different sectors of our society 
and contributes to greater health justice. The involve-
ment of trusted community leaders who represent local 
populations supports effective distribution and vaccine 
uptake in neighborhoods with high rates of infection.
Prioritizing Home Health Workers as Frontline 
Health Care Workers
Going forward, vaccine allocation should prioritize 
home health workers as frontline health care workers.  
Home health workers include home health aides, 
visiting nurses, hospice staff and trained volunteers, 
and physical therapists and occupational therapists 
who make home visits. Plans for vaccine allocation, 
education, and distribution by county health systems 
and by hospitals, community health centers, and other 
health care organizations should ensure access to vacci-
nation for these frontline health care workers. 
Prioritizing home health workers also reaches 
certain low-wage minority workforces, such as home 
health aides, whose members are less visible and less 
protected compared to health care workers employed 
in hospitals, clinics, and long-term care facilities. Home 
health aides’ risk of infection and transmission may be 
significant due to shift work, multiple clients and work 
settings, and residence in neighborhoods with high in-
fection rates.
Ethical Allocation within and between  
Prioritized Groups in the Middle Tier 
Considerations for effective vaccine allocation in the 
middle tier
The middle tier of Covid-19 vaccine allocation fo-
cuses on community-dwelling populations as distinct 
from the much smaller number of people who live in 
long-term care facilities and were prioritized in initial 
allocation. The middle tier also includes congregate 
facilities, such as prisons, jails, immigration detention 
facilities, shelters, and transitional housing, that consti-
tute high-risk environments for infections and include 
populations with special vulnerabilities.
Vaccine distribution to the middle tier should re-
flect planning for vaccine education and vaccination 
in different sites in the same timeframe. See Duty to 
Plan, discussed above, for recommendations concern-
ing vaccine allocation by subgroup when there is insuf-
ficient supply to complete vaccination of a prioritized 
group.
Vaccine distribution to the middle tier should an-
ticipate the potential for vaccine hesitancy and incor-
porate effective strategies to respond to this hesitancy 
among populations prioritized for vaccination.
In the following discussion, we offer consider-
ations for middle-tier vaccine allocation that draw on 
the duties described in this document, with attention 
to foreseeable challenges in ensuring ethical and effec-
tive vaccine distribution to different high-risk popula-
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tions in a county, or a region served by a hospital or 
community health system. These considerations reflect 
epidemiological findings and are aligned with the use 
of public health data to effectively aim vaccines toward 
high-risk populations and toward environments asso-
ciated with viral outbreaks and transmission.
People at high risk of severe Covid-19 
Covid-19 is perilous to older adults, with the high-
est mortality rates in patients ages 85 and older, fol-
lowed by patients ages 75-84. However, age alone is a 
blunt predictor of risk; Covid-19 is also perilous to peo-
ple with multiple comorbidities. Data show significant 
racial variation in Covid-19 mortality rates by age, with 
minority populations frequently experiencing great-
er mortality at younger ages. Allocation based on age 
alone would work against efficacy and equity, because 
primarily white populations would receive vaccines 
ahead of equally at-risk minority populations who are 
somewhat younger. 
In short, age alone should not be used to repre-
sent medical risk. Effective vaccine allocation to in-
dividuals at high risk of severe Covid-19 will need to 
rely on age when information documenting personal-
ized medical risk is unavailable at vaccine distribution 
points.
The use of proxies for age, such as eligibility for 
Medicare or other “senior” services, raises similar ef-
fectiveness and equity concerns. People ages 65-74 who 
do not have multiple comorbidities or other risk factors 
should not be conflated with people at highest risk. 
     
People who live or work in high-risk environments 
Initial recommendations for vaccine allocation 
by ACIP recognized long-term care facilities as high-
risk environments by prioritizing vaccination of resi-
dents and staff. Going forward, ethical approaches to 
vaccine allocation in a county or similar region should 
account for other high-risk environments and consid-
er how limited vaccine supplies should be allocated to 
and within them. Reducing outbreaks within these set-
tings and reducing community spread via people who 
travel to or from high-risk environments are key pub-
lic health goals. Prioritization of vaccination in high-
risk environments also protects people who have little 
or no ability to protect themselves in the places where 
they live or work, including people at risk of severe 
Covid-19.
Essential work and high-risk work environments 
overlap but are not the same. “Essential” occupations 
are those necessary for the functioning of a society. 
In the context of a pandemic and viral transmission, 
some essential workers face much higher risks than 
others. For example, the high risk of frontline health 
care work is evident and borne out by data. Essential 
workers in high-risk environments—typically, congre-
gate indoor sites—who are employed outside of health 
systems need explicit attention in vaccine allocation 
plans. Some essential jobs involve lower risk of infec-
tion or can be done remotely and do not call for special 
prioritization. The word “essential” should not be used 
to broadly indicate risk associated with work environ-
ments.
In short, prioritizing vaccines for people who 
live or work in high-risk environments represents 
an effective approach to controlling the pandemic. 
Overlooking populations known to be at high risk of 
infection is a failure of public health duties. 
Vulnerable populations in high-risk environments
Congregate indoor sites such as long-term care fa-
cilities; jails, prisons, and immigration detention facil-
ities; meatpacking facilities, and overcrowded housing 
are strongly associated with high risk of viral transmis-
sion, often producing severe Covid-19 illness due to 
the medical and social vulnerabilities of populations in 
these settings. Carceral systems, including immigration 
detention facilities, are associated with poor quality 
health care and high risk of Covid-19 (Marshall Proj-
ect, 2020; Chotiner, 2020); 90 of the 100 largest clusters 
of Covid-19 cases in the U.S. have arisen in jails and 
prisons (Siva, 2020). Clusters of infection and severe 
Covid-19 have been associated with meatpacking fa-
cilities, which often employ immigrants vulnerable to 
exploitation. Infection and severe Covid-19 have also 
been associated with overcrowded housing in urban, 
suburban, and rural counties (Ahmad et al., 2020; 
Emeruwa et al., 2020).
Public health officials have special legal and ethical 
duties to ensure that people in custody receive appro-
priate health care, including preventative health care 
such as vaccinations, because they are prevented from 
seeking health care on their own. For example, the 
U.S. Supreme Court has recognized (Estelle v Gamble, 
1976) that deliberate indifference to the serious medical 
needs of incarcerated people violates the Constitution.   
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Applying ethical principles and public health data to 
vaccine allocation in high-risk environments 
After ensuring access to vaccination for people at 
highest risk of severe Covid-19—namely, people 75 
and older and people with multiple comorbidities—an 
ethical approach to vaccine allocation, guided by data, 
would prioritize people who live or work in three high-
risk environments featuring enclosed spaces, close con-
tact with other people, and vulnerable populations. (A 
county or region may not include all three settings.)
People who live or work in carceral and immigra-
tion detention environments
l These high-risk environments are associated with 
       viral outbreaks.
n Incarcerated and detained populations are 
vulnerable populations with little or no ability to 
protect themselves or demand safer conditions.
n Incarcerated and detained populations may 
include people at high risk of severe Covid-19 
due to age or comorbidities.
n Stigma and disempowerment associated with 
being in custody increases incarcerated and de-
tained populations’ vulnerability to being over-
looked or demoted in vaccine prioritization de-
spite high risks.
n Corrections officers and guards in immigra-
tion detention facilities work in high-risk envi-
ronments.
l Frequent movement of people within or between 
       facilities creates further opportunities for infection 
       and transmission.
n Corrections officers and detention facility 
guards may be vectors of viral transmission to or 
from households.
n People held in jail for brief periods may be vec-
tors of viral transmission to or from households.
n Transfer of noncitizens between detention fa-
cilities in different states has contributed to viral 
outbreaks in several states.
Food supply workers in meatpacking facilities
l These high-risk environments are associated with 
       viral outbreaks.
n The workers are a vulnerable population with 
limited ability to protect themselves and with 
few advocates, e.g., union representatives, for 
their occupational health and safety.
n This low-wage population is likely to live in 
overcrowded households, which are often as-
sociated with viral transmission and severe 
Covid-19 illness.
n The workers may be vectors of viral transmis-
sion to or from households.
Residents of neighborhoods with high infection 
        rates 
l These people are likely to live in overcrowded 
households associated with viral transmission and 
severe Covid-19 illness.
n Residents may include people at high risk of 
severe Covid-19 due to age or comorbidities.
n Vaccine prioritization by neighborhood should 
include residents and staff in public housing.
n Prioritization by neighborhood should include 
residents and staff in shelters and transition-
al housing and clients and frontline workers in 
programs serving unhoused populations. 
• Neighborhood-level data may reflect out-
breaks associated with college students living 
in dormitories or other congregate settings. 
Students who live away from home can take 
steps, including remote learning, to protect 
themselves and others from infection. As long 
as vaccine supplies are limited, vaccinating stu-
dents who live away from home should be a 
lower priority.
l Collaboration among county health depart-
ments and clinics serving neighborhoods with 
high infection rates is recommended to refine pri-
oritization plans, develop and implement effective 
vaccine education campaigns, and ensure accessi-
ble vaccination sites. 
n Tools such as the Pandemic Vulnerability In-
dex (PVI) or Social Vulnerability Index (SVI) 
may aid in prioritizing vaccine allocation by 
neighborhood.
n Local public health data could also be used to 
prioritize vaccine allocation for neighborhoods 
experiencing high rates of Covid-19 transmis-
sion.
l
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l Prioritization by neighborhood may also include 
bus drivers and other transit workers who interact 
with the public in neighborhoods with high infec-
tion rates and who work in enclosed spaces.
The following occupations constitute examples 
of essential work in high-risk and moderate-risk en-
vironments without the special vulnerabilities of the 
populations described above. Individuals in these oc-
cupations may have medical or other risk factors, such 
as comorbidities or residence in a neighborhood with 
high infection rates, that would warrant earlier access 
to a vaccine:
l clerks in essential public-facing businesses such 
as grocery stores, pharmacies, and post offices;
l food and medical supply workers who interact 
with the public, e.g., takeout and delivery workers;
l food and medical supply workers who do not in-
teract with the public, e.g., kitchen and warehouse 
workers;
l teachers working in classrooms and other front-
line education workers; and 
l teachers preparing to work in classrooms and 
other frontline education workers.
n Vaccination is crucial to reopening schools and 
repairing the negative social impacts of inter-
rupted education, which have fallen most heavi-
ly on minority and low-income populations.
A large range of nonessential businesses are likely 
to remain closed or restricted until the general public 
is vaccinated and community immunity is achieved. 
Workers in nonessential businesses should be vacci-
nated with the general public unless they have medical 
or environmental risks justifying prioritization, as out-
lined above.
The Role of Vaccination in Health Justice
Data on the disproportionate impact of Covid-19 
on racialized populations have informed the devel-
opment and critical review of proposals for allocating 
scarce resources. Equity in the allocation of scarce, 
potentially beneficial drugs or vaccines should be con-
nected to larger clinical, organizational, and public pol-
icy initiatives to uproot social inequalities that produce 
health inequities; heightened access alone will not mit-
igate inequalities and resulting inequities. Approaches 
to vaccine allocation should be reviewed and refined 
in light of emerging data on safety and efficacy to safe-
guard vulnerable populations from undue risks and 
burdens.
This document describes population health ap-
proaches to vaccine allocation that use epidemiological 
data and tools to identify vulnerable populations and 
respond proactively to vaccine hesitancy in a commu-
nity. These approaches offer ways to integrate health 
justice considerations into vaccine allocation plans in 
the U.S. Access to vaccination is also crucial to pop-
ulation health globally. Because vaccine supplies have 
been reserved by wealthy nations, residents of low- and 
middle-income nations (LMICs) are facing long waits 
for vaccine access. Detailed guidance on this topic is 
beyond the scope of this document. Going forward, 
federal-level participation by the U.S. and other wealthy 
nations in global initiatives to ensure that vaccine sup-
plies are shared with LMICs and with vulnerable pop-
ulations such as refugees should be part of ethical and 
effective pandemic response (Bollyky et al., 2020).
Additional Recommendations  
Supporting Ethical Allocation 
l Involve hospital and system bioethicists and 
community partners in deliberations concerning re-
gional allocation to prioritized settings and groups.
l Share promising practices via professional asso-
ciations of public health and health care organizations.
l Conduct rapid-response research to understand 
and effectively respond to vaccine skepticism and hesi-
tancy in workforce, community, and cultural contexts.
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